Navigation Links
Mindray to Hold Annual General Meeting in Hong Kong on December 28, 2012
Date:12/4/2012

SHENZHEN, China, Dec. 4, 2012 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will hold its 2012 annual general meeting of record at the Company's Hong Kong office (Room 2813, Convention Plaza Office Tower, 1 Harbour Road, Wanchai, Hong Kong) at 10:30 a.m. on December 28, 2012 Beijing/Hong Kong Time (9:30 p.m. on December 27, 2012 U.S. Eastern Time). The shareholder record date is December 3, 2012.

Mindray has filed its annual report on Form 20-F, including its audited financial statements for the fiscal year ended December 31, 2011, with the U.S. Securities and Exchange Commission (the "SEC"). Mindray's Form 20-F and proxy materials can be accessed on the Investor Relations section of the Company's website at http://ir.mindray.com and on the SEC's website at http://www.sec.gov. Shareholders may request a hard copy of the complete audited financial statements on 20-F free of charge by contacting ir@mindray.com.

About Mindray

Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit: www.mindray.com

For investor and media inquiries, please contact:

In the U.S:
Hoki Luk
Western Bridge, LLC
Tel:    +1-646-808-9150
Email:  hoki.luk@westernbridgegroup.com

In China:
Cathy Gao
Mindray Medical International Limited
Tel:      +86-755-8188-8023
Email:  cathy.gao@mindray.com


'/>"/>
SOURCE Mindray Medical International Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray to Showcase Enhancements to DC-8 Ultrasound System at RSNA
2. Mindray DS USA, Inc. has Initiated a Voluntary Recall Affecting the A3/A5 Anesthesia Delivery System
3. Mindray Medical Announces Top Management Change
4. Mindray Medical to Participate in MEDICA 2012 in Dusseldorf, Germany
5. Mindray Announces Second Quarter 2012 Financial Results
6. Mindray to Report Second Quarter 2012 Financial Results on August 6, 2012
7. Mindray Medical Completes Acquisition of Dragonbios Orthopedics Business
8. Mindray Medical to Present at AACC Clinical Lab Expo 2012
9. Mindray Announces First Quarter 2012 Financial Results
10. Mindray Medical to Acquire Controlling Stake in Hangzhou Optcla Medical Instrument
11. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):